Here are Thursday’s biggest calls on Wall Street.
Category: Uncategorized
Core Scientific gets upgrade from Roth as CoreWeave deal becomes less likely
Roth Capital Partners believes that shares of Core Scientific could rally 27% from here.
Deutsche Bank upgrades this bank stock, says it can clear a low earnings bar
Deutsche Bank sees shares of U.S. Bancorp moving 11% higher from here.
Tesla third-quarter earnings missed expectations. Here’s how analysts reacted
Shares slipped after the EV maker reported third-quarter adjusted earnings of 50 cents per share, missing the 54 cents per share analysts expected.
Netflix is trading near levels that could make or break the streaming giant, according to the charts
Frank Cappelleri breaks down the technical outlook on Netflix after the company’s Wednesday drop.
Tesla earnings are coming Wednesday. Here’s what top analysts expect
Analysts are largely split on Tesla heading into the electric vehicle maker’s third-quarter earnings.
Amazon’s switch to robots over human warehouse employees will save it up to $4 billion a year, Morgan Stanley says
“The market is under-appreciating AMZN’s GenAI advances in its Retail business with robotics-driven efficiencies,” analyst Brian Nowak said.
Citigroup says shares of this obesity drug biotech could nearly double
BioAge Labs’ novel obesity treatment could boost the biotechnology company’s stock, the Wall Street bank says.
A potential ‘home run’ trade is emerging in this pharma stock
Tony Zhang breaks down how to trade this stock using options.
Deutsche Bank initiates AppLovin at buy rating, sees growth within ‘best in class’ e-commerce advertising
Deutsche Bank sees shares of AppLovin rising 28% from here.